IXC — Invex Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- AU$6.01m
- -AU$0.14m
- AU$1.26m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 12.2 | 26.3 | 32.7 | 29.3 | 22.5 |
Net Total Receivables | 0.086 | 0.117 | 0.021 | 0.146 | 0.334 |
Total Current Assets | 12.3 | 26.4 | 32.7 | 29.5 | 22.8 |
Net Intangible Assets | |||||
Total Assets | 12.4 | 26.4 | 32.7 | 29.5 | 22.8 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.935 | 2.02 | 0.659 | 1 | 1.57 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.935 | 2.02 | 0.659 | 1 | 1.57 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 11.4 | 24.4 | 32.1 | 28.5 | 21.2 |
Total Liabilities & Shareholders' Equity | 12.4 | 26.4 | 32.7 | 29.5 | 22.8 |
Total Common Shares Outstanding |